The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

AZN ASTRAZENECA PLC ORD SHS $0.25



Income Statement  (£ m) 31-Dec-12 31-Dec-13 31-Dec-14 31-Dec-15 31-Dec-16
Continuing Operations
Revenue  17654.57 16503.71 16124.38 16172.13 17039.88
Operating Profit/(Loss)  5142.44 2373.94 1297.99 2692.74 3631.40
Net Interest  268.86 264.13 253.89 256.58 457.07
Profit Before Tax  4825.61 2089.35 756.81 2008.75 2631.32
Profit After Tax  3957.18 1644.23 750.13 1849.70 2523.17
Discontinued Operations
Profit After Tax  0.00 0.00 0.00 0.00 0.00
PROFIT FOR THE PERIOD  3957.18 1644.23 750.13 1849.70 2523.17
Attributable to:
Minority Interests  -18.93 -9.59 -1.22 -0.66 68.89
Equity Holders of Parent Company  3938.24 1634.64 748.91 1849.05 2592.06
 
Continuing EPS
Earnings per Share - Basic  312.41p 130.46p 59.52p 145.96p 205.20p
Earnings per Share - Diluted  311.78p 130.46p 59.52p 145.96p 204.46p
Earnings per Share - Adjusted  312.41p 130.46p 59.52p 145.96p 205.20p
Continuing and Discontinued EPS
Earnings per Share - Basic  312.41p 130.46p 59.52p 145.96p 205.20p
Earnings per Share - Diluted  311.78p 130.46p 59.52p 145.96p 204.46p
Earnings per Share - Adjusted  312.41p 130.46p 59.52p 145.96p 205.20p
 
Dividend per Share  181.70p 179.70p 169.90p 182.50p 199.70p

Balance Sheet  (£ m) 31-Dec-12 31-Dec-13 31-Dec-14 31-Dec-15 31-Dec-16
Assets
Non-Current Assets
Property, Plant & Equipment  3391.57 3047.23 3136.10 3287.19 3687.13
Intangible Assets  16207.94 15714.93 20863.11 23370.58 31759.78
Investment Properties  0.00 0.00 0.00 0.00 0.00
Investments  122.42 169.66 37.84 57.67 80.12
Other Financial Assets  239.31 220.38 298.22 302.60 277.59
Other Non-Current Assets  1254.38 2320.29 2535.18 2867.89 4064.26
  21215.63 21472.48 26870.44 29885.93 39868.86
Current Assets
Inventories  1267.92 1152.60 1257.01 1453.96 1888.88
Trade & Other Receivables  5187.33 5055.37 4849.10 4755.40 4045.64
Cash at Bank & in Hand  4737.62 5564.95 4078.86 4233.65 4061.02
Current Asset Investments  525.38 504.75 523.33 417.26 737.26
Other Current Assets  0.00 0.00 0.00 0.00 0.00
  11718.24 12277.66 10708.29 10860.27 10732.80
 
Total Assets  32933.87 33750.14 37578.73 40746.19 50601.67
 
Liabilities
Current Liabilities
Borrowings  -554.29 -1079.54 -1568.69 -621.48 -1867.03
Other Current Liabilities  -7998.77 -8611.57 -9545.56 -9466.69 -10479.49
  -8553.06 -9691.11 -11114.25 -10088.17 -12346.53
 
Net Current Assets  3165.18 2586.55 -405.96 772.10 -1613.72
 
Non-Current Liabilities
Borrowings  -5788.37 -5185.18 -5385.25 -9591.53 -11735.52
Provisions  -1848.05 -2048.59 -1462.23 -2109.36 -3487.23
Other Non-Current Liabilities  -2012.92 -2785.80 -7017.43 -6399.33 -9542.34
  -9649.34 -10019.56 -13864.91 -18100.22 -24765.08
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  -18202.40 -19710.68 -24979.16 -28188.39 -37111.61
 
Net Assets  14731.47 14039.46 12599.57 12557.80 13490.06
 
Capital & Reserves
Share Capital  191.94 190.19 202.66 214.40 255.74
Share Premium Account  2155.64 2404.82 2732.71 2920.14 3521.22
Other Reserves  1205.78 1187.01 1296.13 1381.37 1656.62
Retained Earnings  11045.83 10239.94 8355.89 8029.01 6587.62
Shareholders Funds  14599.20 14021.96 12587.38 12544.91 12021.20
 
Minority Interests/Other Equity  132.27 17.51 12.19 12.89 1468.86
Total Equity  14731.47 14039.46 12599.57 12557.80 13490.06

Ratios - based on IFRS 31-Dec-12 31-Dec-13 31-Dec-14 31-Dec-15 31-Dec-16
Continuing Operations
PE Ratio - Adjusted  9.31 27.40 76.54 31.63 21.63
PEG - Adjusted  -0.29 -0.47 -1.41 0.22 0.53
Earnings per Share Growth - Adjusted  -31.68% -58.24% -54.38% 145.21% 40.59%
Dividend Cover  1.72 0.73 0.35 0.80 1.03
Revenue Per Share  1400.05p 1318.19p 1277.68p 1279.44p 1347.03p
Pre-Tax Profit per Share  382.68p 166.88p 59.97p 158.92p 208.01p
Operating Margin  28.83% 14.07% 6.11% 13.89% 18.15%
Return on Capital Employed  62.81% 29.41% 49.42% 79.52% 524.20%
 
Continuing & Discontinued Operations
Dividend Yield  6.25% 5.03% 3.73% 3.95% 4.50%
Dividend per Share Growth  7.77% -1.10% -5.45% 7.42% 9.42%
Net Asset Value per Share (exc. Intangibles)  -129.01p -134.67p -655.17p -856.38p -1560.08p
Net Gearing  10.99% 4.99% 22.84% 47.66% 79.37%

Data is provided by Morningstar



Company Information
Updated Monthly
Company address 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA, United Kingdom
Company website http://www.astrazeneca....
Market cap(in millions)* £ 65,205.81
Listing/Admission to trading 01 Jun 1993
Trading service SETS
Market Main Market
Listing category Premium Equity Commercial Companies
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
23-Jul-17
FTSE index FTSE All-Share,FTSE Eurotop 300,FTSE 350 High Yield,FTSE 100,FTSE 350 (ex IT),FTSE techMARK All-Share,FTSE All-Share (ex IT),FTSE 350
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register GB
Segment SET0
MiFID Status Regulated Market
Exchange market size 500
SEDOL 0989529
ISIN number GB0009895292



ASTRAZENECA share fundamentals (AZN)